269 related articles for article (PubMed ID: 12687271)
1. Different patterns of chromogranin A and Leu-7 (CD57) expression in gastrointestinal carcinoids: immunohistochemical and confocal laser scanning microscopy study.
Jirásek T; Hozák P; Mandys V
Neoplasma; 2003; 50(1):1-7. PubMed ID: 12687271
[TBL] [Abstract][Full Text] [Related]
2. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
3. [Carcinoids of the gastrointestinal tract: importance of determining differentiation and proliferation markers].
Jirásek T; Mandys V
Cesk Patol; 2003 Apr; 39(2):47-53. PubMed ID: 12874899
[TBL] [Abstract][Full Text] [Related]
4. Ultrastructure and chromogranin A immunogold labelling of ECL cell carcinoids.
Fossmark R; Martinsen TC; Qvigstad G; Bendheim MØ; Kopstad G; Kashima K; Waldum HL
APMIS; 2005; 113(7-8):506-12. PubMed ID: 16086820
[TBL] [Abstract][Full Text] [Related]
5. Primary neuroendocrine carcinoma (thymic carcinoid) of the thymus with prominent oncocytic features: a clinicopathologic study of 22 cases.
Moran CA; Suster S
Mod Pathol; 2000 May; 13(5):489-94. PubMed ID: 10824919
[TBL] [Abstract][Full Text] [Related]
6. Primary renal carcinoid. Case report and literature review.
Goldblum JR; Lloyd RV
Arch Pathol Lab Med; 1993 Aug; 117(8):855-8. PubMed ID: 7688215
[TBL] [Abstract][Full Text] [Related]
7. Secretoneurin in carcinoids of the appendix-immunohistochemical comparison with chromogranins A,B and secretogranin II.
Prommegger R; Obrist P; Ensinger C; Schwelberger HG; Wolf C; Fischer-Colbrie R; Mikuz G; Bodner E
Anticancer Res; 1998; 18(6A):3999-4002. PubMed ID: 9891437
[TBL] [Abstract][Full Text] [Related]
8. Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin.
Gazdar AF; Helman LJ; Israel MA; Russell EK; Linnoila RI; Mulshine JL; Schuller HM; Park JG
Cancer Res; 1988 Jul; 48(14):4078-82. PubMed ID: 3383200
[TBL] [Abstract][Full Text] [Related]
9. Chromogranin A expression in human colonic adenocarcinoma.
Romeo R; Pellitteri R; Mazzone V; Marcello MF
Ital J Anat Embryol; 2002; 107(3):177-83. PubMed ID: 12437144
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine differentiation in ovarian mucinous tumors.
Jiang C; Tan Y; Li E; Zhang D
Chin Med J (Engl); 2000 Jan; 113(1):70-4. PubMed ID: 11775215
[TBL] [Abstract][Full Text] [Related]
11. Pigmented thymic carcinoids: a clinicopathological and immunohistochemical study of two cases.
Klemm KM; Moran CA; Suster S
Mod Pathol; 1999 Oct; 12(10):946-8. PubMed ID: 10530558
[TBL] [Abstract][Full Text] [Related]
12. Chromogranin A plasma concentration and expression in pancreatic islet cell tumors of dogs and cats.
Myers NC; Andrews GA; Chard-Bergstrom C
Am J Vet Res; 1997 Jun; 58(6):615-20. PubMed ID: 9185968
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine differentiation in non-small cell lung carcinomas.
Baldi A; Groger AM; Esposito V; Di Marino MP; Ferrara N; Baldi F
In Vivo; 2000; 14(1):109-14. PubMed ID: 10757067
[TBL] [Abstract][Full Text] [Related]
14. The biological characteristics of chromogranin A and its role as a circulating marker in neuroendocrine tumours.
Ferrari L; Seregni E; Bajetta E; Martinetti A; Bombardieri E
Anticancer Res; 1999; 19(4C):3415-27. PubMed ID: 10629629
[TBL] [Abstract][Full Text] [Related]
15. Expression of cyclo-oxygenase-2 in gastrointestinal carcinoid tumors.
Mizuno S; Kato K; Hashimoto A; Sugitani M; Sheikh A; Komuro S; Jike T; Iwasaki A; Arakawa Y; Nemoto N
J Gastroenterol Hepatol; 2006 Aug; 21(8):1313-9. PubMed ID: 16872316
[TBL] [Abstract][Full Text] [Related]
16. Bronchopulmonary carcinoid tumors--a significant diagnostic problem.
Kedra P; Jeleń M; Szkudlarek-Gruszczyńska T; Leśkow E
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():146-61. PubMed ID: 9337533
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic and DNA cytometric analysis of carcinoid tumors of the thymus.
Goto K; Kodama T; Matsuno Y; Yokose T; Asamura H; Kamiya N; Shimosato Y
Mod Pathol; 2001 Oct; 14(10):985-94. PubMed ID: 11598168
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical and ultrastructural features of neuroendocrine differentiated carcinomas of the prostate: an immunoelectron microscopic study.
Hirano D; Jike T; Okada Y; Minei S; Sugimoto S; Yamaguchi K; Yoshikawa T; Hachiya T; Yoshida T; Takimoto Y
Ultrastruct Pathol; 2005; 29(5):367-75. PubMed ID: 16257863
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor.
Zhao C; Bratthauer GL; Barner R; Vang R
Am J Surg Pathol; 2007 Sep; 31(9):1378-86. PubMed ID: 17721194
[TBL] [Abstract][Full Text] [Related]
20. Secretagogin is a novel marker for neuroendocrine differentiation.
Birkenkamp-Demtröder K; Wagner L; Brandt Sørensen F; Bording Astrup L; Gartner W; Scherübl H; Heine B; Christiansen P; Ørntoft TF
Neuroendocrinology; 2005; 82(2):121-38. PubMed ID: 16449819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
